Experts has a new look! Let us know what you think of the updates.

Provide feedback

Scholarly Works

Phase I trial of granulocyte-macrophage...

Journal article

Phase I trial of granulocyte-macrophage colony-stimulating factor with high-dose cisplatin and etoposide for treatment of small-cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group.

Authors

SHEPHERD FA; GOSS PE; RUSTHOVEN J; EISENHAUER EA

Journal

Journal of the National Cancer Institute, Vol. 84, No. 1, pp. 59–60

Publisher

Oxford University Press (OUP)

Publication Date

January 1, 1992

DOI

10.1093/jnci/84.1.59

ISSN

0027-8874

Associated Experts

James Rusthoven

Professor Emeritus, Faculty of Health Sciences

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3211 Oncology and carcinogenesis

Medical Subject Headings (MeSH)

Aged Antineoplastic Combined Chemotherapy Protocols Carcinoma, Small Cell Cisplatin Drug Evaluation Etoposide Female Granulocyte-Macrophage Colony-Stimulating Factor Humans Lung Neoplasms Male Middle Aged

View published work (Non-McMaster Users)

View published work (McMaster Users)